Breeur, Marie
Ferrari, Pietro
Dossus, Laure
Jenab, Mazda
Johansson, Mattias
Rinaldi, Sabina
Travis, Ruth C.
His, Mathilde
Key, Tim J.
Schmidt, Julie A.
Overvad, Kim
Tjønneland, Anne
Kyrø, Cecilie
Rothwell, Joseph A.
Laouali, Nasser
Severi, Gianluca
Kaaks, Rudolf
Katzke, Verena
Schulze, Matthias B.
Eichelmann, Fabian
Palli, Domenico
Grioni, Sara
Panico, Salvatore
Tumino, Rosario
Sacerdote, Carlotta
Bueno-de-Mesquita, Bas
Olsen, Karina Standahl
Sandanger, Torkjel Manning
Nøst, Therese Haugdahl
Quirós, J. Ramón
Bonet, Catalina
Barranco, Miguel Rodríguez
Chirlaque, María-Dolores
Ardanaz, Eva
Sandsveden, Malte
Manjer, Jonas
Vidman, Linda
Rentoft, Matilda
Muller, David
Tsilidis, Kostas
Heath, Alicia K.
Keun, Hector
Adamski, Jerzy
Keski-Rahkonen, Pekka
Scalbert, Augustin
Gunter, Marc J.
Viallon, Vivian
Funding for this research was provided by:
Institut National Du Cancer (2015-166, 2009-139, 2014-1-RT-02-CIRC-1)
World Cancer Research Fund (2013/1002, 2014/1193, 2014/1183)
European Commission (313010, 313010)
Cancer Research UK Cambridge Institute, University of Cambridge (C19335/A21351, C8221/A19170, 14136, C8221/A29017)
Centre International de Recherche sur le Cancer
Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London
NIHR Imperial Biomedical Research Centre
Kræftens Bekæmpelse
Ligue Contre le Cancer
Institut Gustave-Roussy
Mutuelle Générale de l'Education Nationale
Institut National de la Santé et de la Recherche Médicale
Deutsche Krebshilfe
Deutsches Krebsforschungszentrum
Deutsche Institut für Ernährungsforschung Potsdam-Rehbrücke
Bundesministerium für Bildung und Forschung
Associazione Italiana per la Ricerca sul Cancro
Compagnia di San Paolo
Consiglio Nazionale delle Ricerche
Ministerie van Volksgezondheid, Welzijn en Sport
Nederlandse Kankerregistratie
LK Research Funds
Dutch Prevention Funds
Zorg Onderzoek Nederland
Statistics Netherlands
Instituto de Salud Carlos III
Gobierno del Principado de Asturias
Junta de Andalucía
Eusko Jaurlaritza
Comunidad Autónoma de la Región de Murcia
Gobierno de Navarra
Catalan Institute of Oncology
Cancerfonden
Vetenskapsrådet
Skåne County Council
Västerbotten Läns Landsting
Medical Research Council (1000143, MR/M012190/1)
Generalitat de Catalunya
Fondation ARC pour la Recherche sur le Cancer
Article History
Received: 30 March 2022
Accepted: 5 September 2022
First Online: 19 October 2022
Declarations
:
: The EPIC study, and in particular the seven case-control studies nested within EPIC, were conducted according to the Declaration of Helsinki and approved by the ethics committee at the International Agency for Research on Cancer (IARC): on 10 April 2008 (IEC 08-06) and on 11 February 2016 (IEC 16-06) for the liver cancer study, on 7 April 2014 (IEC 14-07) for the breast cancer study, on 7 April 2014 (IEC 14-08) for the two colorectal cancer studies, on 7 April 2014 (IEC 14-09) for the prostate cancer study, on 25 February 2015 (IEC 15-06) for the kidney cancer study, and on 28 April 2016 (IEC 16-20) for the endometrial cancer study. Written informed consent was obtained from all subjects involved in the study.
: Not applicable.
: The authors declare that they have no competing interests.